Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HTR1D | SNV | Missense_Mutation | rs747417217 | c.871N>G | p.Ile291Val | p.I291V | P28221 | protein_coding | deleterious(0.01) | benign(0.386) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | rs556603753 | c.446G>A | p.Arg149His | p.R149H | P28221 | protein_coding | tolerated(0.07) | benign(0.11) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | novel | c.96N>T | p.Arg32Ser | p.R32S | P28221 | protein_coding | tolerated(0.77) | benign(0) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | rs370958543 | c.680N>A | p.Arg227His | p.R227H | P28221 | protein_coding | deleterious(0.03) | benign(0.258) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | | c.424N>T | p.Asp142Tyr | p.D142Y | P28221 | protein_coding | deleterious(0) | probably_damaging(0.954) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
HTR1D | SNV | Missense_Mutation | novel | c.292N>C | p.Tyr98His | p.Y98H | P28221 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | rs753101503 | c.557N>T | p.Ser186Leu | p.S186L | P28221 | protein_coding | tolerated(0.2) | benign(0.005) | TCGA-AX-A1C9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | | c.937T>C | p.Cys313Arg | p.C313R | P28221 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | novel | c.706N>T | p.Gly236Trp | p.G236W | P28221 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HTR1D | SNV | Missense_Mutation | | c.552N>T | p.Glu184Asp | p.E184D | P28221 | protein_coding | tolerated(0.29) | benign(0.077) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | CHEMBL2062265 | | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | | ERGOTAMINE | ERGOTAMINE | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135651366 | ZOLMITRIPTAN | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | | Almogran | | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | CHEMBL1200601 | NARATRIPTAN HYDROCHLORIDE | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | | TGBA01AD | | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 178103687 | ALMOTRIPTAN | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135650081 | | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | | Dihydroergotamine nasal | | |
3352 | HTR1D | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | antagonist | 135652727 | YOHIMBINE | |